PARP1/2 inhibitors were believed to function by trapping these proteins on DNA, thereby leading to accumulation of DNA damage due to replisomes colliding with the DNA-bound PARPs.3 PARP1/2 trapping has been linked with cytotoxicity, particularly to occurrence of anaemia and leukaemia. The gene discussed is PARP1; the disease is anemia.